PCVX vs VRTX: Which Stock is Better?
Side-by-side comparison of Vaxcyte Inc and Vertex Pharmaceuticals Inc in 2026
PCVX
Vaxcyte Inc
$62.35
VRTX
Vertex Pharmaceuticals Inc
$441.20
Key Metrics Comparison
| Metric | PCVX | VRTX | Winner |
|---|---|---|---|
| Market Cap | $9.05B | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 0.0% | 0.1% | VRTX |
| Gross Margin | 0.0% | 53.7% | VRTX |
Analyze PCVX
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCVX or VRTX a better investment?
Comparing PCVX and VRTX: Vaxcyte Inc has a market cap of $9.05B while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCVX and VRTX?
PCVX (Vaxcyte Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCVX or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PCVX or VRTX?
VRTX has higher revenue growth at 0.1% vs 0.0% for PCVX.
Which company is more profitable: PCVX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 0.0% for PCVX.
Which is the larger company: PCVX or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $9.05B for PCVX.
Should I buy PCVX or VRTX in 2026?
Both PCVX and VRTX have investment merit. PCVX trades at $62.35 while VRTX trades at $441.20. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCVX and VRTX stock?
Key differences: Market Cap ($9.05B vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 53.7%).